These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 20193695)
1. DNA methylation changes in a human cell model of breast cancer progression. Fernandez SV; Snider KE; Wu YZ; Russo IH; Plass C; Russo J Mutat Res; 2010 Jun; 688(1-2):28-35. PubMed ID: 20193695 [TBL] [Abstract][Full Text] [Related]
2. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. Wu Y; Alvarez M; Slamon DJ; Koeffler P; Vadgama JV BMC Cancer; 2010 Feb; 10():32. PubMed ID: 20132554 [TBL] [Abstract][Full Text] [Related]
3. All trans-retinoic acid (ATRA) induces re-differentiation of early transformed breast epithelial cells. Arisi MF; Starker RA; Addya S; Huang Y; Fernandez SV Int J Oncol; 2014 Jun; 44(6):1831-42. PubMed ID: 24676586 [TBL] [Abstract][Full Text] [Related]
4. XAF1 is frequently methylated in human esophageal cancer. Chen XY; He QY; Guo MZ World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195 [TBL] [Abstract][Full Text] [Related]
5. The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene. Chua YL; Ito Y; Pole JC; Newman S; Chin SF; Stein RC; Ellis IO; Caldas C; O'Hare MJ; Murrell A; Edwards PA Oncogene; 2009 Nov; 28(46):4041-52. PubMed ID: 19802002 [TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients. Spitzwieser M; Entfellner E; Werner B; Pulverer W; Pfeiler G; Hacker S; Cichna-Markl M BMC Cancer; 2017 Apr; 17(1):260. PubMed ID: 28403857 [TBL] [Abstract][Full Text] [Related]
7. Estrogen and xenoestrogens in breast cancer. Fernandez SV; Russo J Toxicol Pathol; 2010 Jan; 38(1):110-22. PubMed ID: 19933552 [TBL] [Abstract][Full Text] [Related]
8. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac. Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117 [TBL] [Abstract][Full Text] [Related]
9. ERbeta shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins. Chen JQ; Russo PA; Cooke C; Russo IH; Russo J Biochim Biophys Acta; 2007 Dec; 1773(12):1732-46. PubMed ID: 17604135 [TBL] [Abstract][Full Text] [Related]
10. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells. Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Sukocheva O; Siegert G BMC Cancer; 2015 Dec; 15():971. PubMed ID: 26672991 [TBL] [Abstract][Full Text] [Related]
12. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells. Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327 [TBL] [Abstract][Full Text] [Related]
13. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related]
14. Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Huang Y; Fernandez SV; Goodwin S; Russo PA; Russo IH; Sutter TR; Russo J Cancer Res; 2007 Dec; 67(23):11147-57. PubMed ID: 18056439 [TBL] [Abstract][Full Text] [Related]
15. HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer. Acun T; Doberstein N; Habermann JK; Gemoll T; Thorns C; Oztas E; Ried T OMICS; 2017 May; 21(5):257-265. PubMed ID: 28481734 [TBL] [Abstract][Full Text] [Related]
16. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications. Müller I; Wischnewski F; Pantel K; Schwarzenbach H BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761 [TBL] [Abstract][Full Text] [Related]
17. Entropy of Feulgen-stained 17-beta-estradiol-transformed human breast epithelial cells as assessed by restriction enzymes and image analysis. Mello ML; Russo P; Russo J; Vidal BC Oncol Rep; 2009 Jun; 21(6):1483-7. PubMed ID: 19424627 [TBL] [Abstract][Full Text] [Related]
18. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. Mossman D; Kim KT; Scott RJ BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997 [TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer. Douglas DB; Akiyama Y; Carraway H; Belinsky SA; Esteller M; Gabrielson E; Weitzman S; Williams T; Herman JG; Baylin SB Cancer Res; 2004 Mar; 64(5):1611-20. PubMed ID: 14996719 [TBL] [Abstract][Full Text] [Related]
20. DNA methylation of heparanase promoter influences its expression and associated with the progression of human breast cancer. Jiao F; Bai SY; Ma Y; Yan ZH; Yue Z; Yu Y; Wang X; Wang J PLoS One; 2014; 9(3):e92190. PubMed ID: 24632672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]